Across the pharmaceutical supply chain, losses associated with temperature lapses are estimated to be worth £320bn globally. To ensure the profitability of the pharmaceutical industry and patient safety, supply chains must limit the risk of damage to products.
Warehouses are a critical area of risk due to the hectic pace of operations and potential for errors in judgment or processes by workers. To ensure the safe storage and continuity of supply for pharmaceutical products, supply chain leaders must operate with smart warehouse management in mind.
With a rise in precision medicines, high value shipments and emerging shipping routes, global biopharma industry spending on temperature-controlled products is expected to reach $15.7 billion in 2019. To ensure that companies are able to navigate this new product landscape and complex routes in a cost efficient and effective way, they must rely on specialised and trusted partners.
In this report, Pharma IQ explores the current development trends, and how this will affect temperature control and logistics spending in the next 12 to 24 months.
Key benefits of downloading the full report:
- Understand where companies are looking to invest in innovation over the coming year to seek greater insight and oversight on their end-to-end supply chain
- Explore investment opportunities into the implementation of real-time technology to keep up with customer demand, staying ahead of the innovation curve and ensuring better accountability and visibility across the entire supply chain
- Discover how to balance cost, quality and delivery time across shipments
- Equip 3PLs, containers and data loggers with the right information in order to ensure the industry is capable of a strategic transformation in the next 10 years
- Gain a full understanding of the challenges of the supply chain and provide solutions to practically advance the industry past these current hurdles
Download the full report now >>
Supply Chain Resilience: How to build on-the-ground excellence and protect critical business functions
The risks pharmaceutical companies face from natural and man-made disasters are increasing in both frequency and magnitude.
To ensure there is minimal interruption to the production of delivery of patient treatments in the wake of a disaster, supply chain leaders must implement a business continuity plan.
However, many companies are unprepared to protect their critical business functions and products in a complex supply network.
In this report, we shed light on the process of building a resilient supply chain, showing you how to:
- Understand the full scope of risks facing the pharmaceutical supply chain
- Protect and reinforce critical business processes and functions
- Ensure on-the-ground operational engagement
- Encourage a risk mitigation mindset across teams and partners
- Respond to a crisis situation effectively and learn from the process
Download your copy of this report to start building resiliency in your supply chain and secure your products from disaster.
Supply chains in a range of industries, including pharma, are becoming digitised. New research forecasts that the value of the Connected Logistics Market is set to reach US$ 41.00 Billion By 2022. This article will take you through six key elements of data management, explaining how in each area inefficiencies in the supply chain can be removed through the advanced data usage and technology.
Maintaining GDP compliance whilst ensuring cost efficiency throughout the supply chain can often be challenging; selecting the right partners and solutions, and managing them effectively, is critical in order to avoid unnecessary expenditure from the planning stages right through to the last mile.
With insights from over 50 TCL industry professionals, this report will allow you to compare what your peers think about:
- Which areas of the supply chain are the least cost effective
- The most important considerations when selecting supply chain partners
- What new technologies have the potential to uncover efficiencies in supply chain management
We know that striking the balance between cost and GDP compliance is still one of the toughest challenges facing supply chain and logistics professionals today - that's why we have created this Infographic "Benchmarking Report: Are You Spending Too Much?" which allows you to compare your supply chain spending, biggest challenges and planned investments with that of the rest of the industry.
The key steps that need to be taken to build a successful temperature controlled supply chain in emerging pharmaceutical regions are in some cases vastly different to those faced in developed markets. This eBook will take you through the considerations that should be made when planning your supply chain, with a particular focus on Russia. The areas we have chosen to focus on are connectivity, regulations, demand planning, cost efficiency and flexibility.
This handy guide provides an overview of the decision making process for solution adoption in temperature controlled logistics and the key steps that need to be taken from the vendor perspective in order to give your solution the best chance of customer success.
With the growth in new generation technologies and smart solutions, the vendor cold chain solutions market is becoming an increasingly competitive, and there are a number of important considerations that need to be made in order to maximise your chances of success in selling your solution.
Approximately one-third of the medicines manufactured in Europe and the United States are now being tested and labeled for storage at controlled room temperature (CRT), mostly in the range of 15°C to 25°C and the proportion is increasing.
Pharma IQ sat down with Steve Winyard, Portfolio Strategy Manager Life Sciences at Inmark to discuss best practices for CRT transportation, an area which is facing increasing global regulatory scrutiny.